FDA approves whooping cough vaccine for pregnant mothers

The Food and Drug Administration authorised a new vaccination to prevent whooping cough in newborn newborns on Friday

GlaxoSmithKline produces Boostrix, which is intended for usage during the third trimester of pregnancy

It was the first vaccination approved by the agency that protects newborns from disease by giving their moms a shot during pregnancy

Marks stated in a statement that "pertussis disease is a highly contagious respiratory ailment affecting all age groups."

However, babies are most susceptible to contracting pertussis and suffering terrible side effects from it

According to the FDA, the single-shot vaccine was 78% effective in preventing whooping cough in newborn infants

FOR MORE STORIES

Click Here